BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 17222547)

  • 21. Identification and characterization of a 500-kb homozygously deleted region at 1p36.2-p36.3 in a neuroblastoma cell line.
    Ohira M; Kageyama H; Mihara M; Furuta S; Machida T; Shishikura T; Takayasu H; Islam A; Nakamura Y; Takahashi M; Tomioka N; Sakiyama S; Kaneko Y; Toyoda A; Hattori M; Sakaki Y; Ohki M; Horii A; Soeda E; Inazawa J; Seki N; Kuma H; Nozawa I; Nakagawara A
    Oncogene; 2000 Aug; 19(37):4302-7. PubMed ID: 10980605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular analysis of the region of distal 1p commonly deleted in neuroblastoma.
    White PS; Maris JM; Sulman EP; Jensen SJ; Kyemba SM; Beltinger CP; Allen C; Kramer DL; Biegel JA; Brodeur GM
    Eur J Cancer; 1997 Oct; 33(12):1957-61. PubMed ID: 9516832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutations in the N-terminal domain of DFF45 in a primary germ cell tumor and in neuroblastoma tumors.
    Abel F; Sjöberg RM; Krona C; Nilsson S; Martinsson T
    Int J Oncol; 2004 Nov; 25(5):1297-302. PubMed ID: 15492818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid and accurate determination of MYCN copy number and 1p deletion in neuroblastoma by quantitative PCR.
    Anderson J; Gibson S; Williamson D; Rampling D; Austin C; Shipley J; Sebire N; Brock P
    Pediatr Blood Cancer; 2006 Jun; 46(7):820-4. PubMed ID: 16220551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In-situ cytidine-deaminase activity and chromosome 1P deletion in human neuroblastoma cells.
    Slingerland RJ; Van Gennip AH; Bodlaender JM; Voûte PA; Van Kuilenburg AB
    Anticancer Res; 1997; 17(1A):457-9. PubMed ID: 9066694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of Calmodulin Binding Transcription Activator 1 (CAMTA1) gene and its putative genetic partners in the human nervous system.
    Alves G; Ornellas MH; Liehr T
    Psychogeriatrics; 2022 Nov; 22(6):869-878. PubMed ID: 35949142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analyses of apoptotic regulators CASP9 and DFFA at 1P36.2, reveal rare allele variants in human neuroblastoma tumours.
    Abel F; Sjöberg RM; Ejeskär K; Krona C; Martinsson T
    Br J Cancer; 2002 Feb; 86(4):596-604. PubMed ID: 11870543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroblastoma consensus deletion maps to 1p36.1-2.
    Weith A; Martinsson T; Cziepluch C; Brüderlein S; Amler LC; Berthold F; Schwab M
    Genes Chromosomes Cancer; 1989 Nov; 1(2):159-66. PubMed ID: 2487156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of the homozygously deleted region at chromosome 1p36.2 in human neuroblastoma.
    Nakagawara A; Ohira M; Kageyama H; Mihara M; Furuta S; Machida T; Takayasu H; Islam A; Nakamura Y; Takahashi M; Shishikura T; Kaneko Y; Toyoda A; Hattori M; Sakaki Y; Ohki M; Horii A; Soeda E; Inazawa J; Seki N; Kuma H; Nozawa I; Sakiyama S
    Med Pediatr Oncol; 2000 Dec; 35(6):516-21. PubMed ID: 11107106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-resolution genomic copy number profiling of glioblastoma multiforme by single nucleotide polymorphism DNA microarray.
    Yin D; Ogawa S; Kawamata N; Tunici P; Finocchiaro G; Eoli M; Ruckert C; Huynh T; Liu G; Kato M; Sanada M; Jauch A; Dugas M; Black KL; Koeffler HP
    Mol Cancer Res; 2009 May; 7(5):665-77. PubMed ID: 19435819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroblastomas have distinct genomic DNA profiles that predict clinical phenotype and regional gene expression.
    Mosse YP; Diskin SJ; Wasserman N; Rinaldi K; Attiyeh EF; Cole K; Jagannathan J; Bhambhani K; Winter C; Maris JM
    Genes Chromosomes Cancer; 2007 Oct; 46(10):936-49. PubMed ID: 17647283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fine mapping of the human preprocortistatin gene (CORT) to neuroblastoma consensus deletion region 1p36.3-->p36.2, but absence of mutations in primary tumors.
    Ejeskär K; Abel F; Sjöberg R; Bäckström J; Kogner P; Martinsson T
    Cytogenet Cell Genet; 2000; 89(1-2):62-6. PubMed ID: 10894940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells.
    Welch C; Chen Y; Stallings RL
    Oncogene; 2007 Jul; 26(34):5017-22. PubMed ID: 17297439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intragenic CAMTA1 rearrangements cause non-progressive congenital ataxia with or without intellectual disability.
    Thevenon J; Lopez E; Keren B; Heron D; Mignot C; Altuzarra C; Béri-Dexheimer M; Bonnet C; Magnin E; Burglen L; Minot D; Vigneron J; Morle S; Anheim M; Charles P; Brice A; Gallagher L; Amiel J; Haffen E; Mach C; Depienne C; Doummar D; Bonnet M; Duplomb L; Carmignac V; Callier P; Marle N; Mosca-Boidron AL; Roze V; Aral B; Razavi F; Jonveaux P; Faivre L; Thauvin-Robinet C
    J Med Genet; 2012 Jun; 49(6):400-8. PubMed ID: 22693284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allelic loss of chromosome 1p in neuroblastoma.
    Kushner BH; Cheung NK
    N Engl J Med; 1996 Jun; 334(24):1608-9. PubMed ID: 8628350
    [No Abstract]   [Full Text] [Related]  

  • 36. Reassignment of the EPB4.1 gene to 1p36 and assessment of its involvement in neuroblastomas.
    Huang S; Lichtenauer UD; Pack S; Wang C; Kim AC; Lutchman M; Koch CA; Torres-Cruz J; Huang SC; Benz EJ; Christiansen H; Dockhorn-Dworniczak B; Poremba C; Vortmeyer AO; Chishti AH; Zhuang Z
    Eur J Clin Invest; 2001 Oct; 31(10):907-14. PubMed ID: 11737230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 1p36 tumor suppression--a matter of dosage?
    Henrich KO; Schwab M; Westermann F
    Cancer Res; 2012 Dec; 72(23):6079-88. PubMed ID: 23172308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional characterization of a new p53 mutant generated by homozygous deletion in a neuroblastoma cell line.
    Nakamura Y; Ozaki T; Niizuma H; Ohira M; Kamijo T; Nakagawara A
    Biochem Biophys Res Commun; 2007 Mar; 354(4):892-8. PubMed ID: 17276397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intragenic CAMTA1 deletions are associated with a spectrum of neurobehavioral phenotypes.
    Shinawi M; Coorg R; Shimony JS; Grange DK; Al-Kateb H
    Clin Genet; 2015 May; 87(5):478-82. PubMed ID: 24738973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuropsychological and neuroimaging phenotype induced by a CAMTA1 mutation.
    Magnin E; Blagosklonov O; Sylvestre G; Minot D; Thevenon J; Faivre L; Boulahdour H; Thauvin-Robinet C; Rumbach L
    Brain Dev; 2014 Sep; 36(8):711-5. PubMed ID: 24145135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.